Eloralintide – 10mg

Eloralintide (10mg) — Research Compound

Eloralintide is a long-acting synthetic peptide designed to mimic a natural hormone in the body called amylin, which controls fullness. It is modified to stay active in the body for a longer period of time, allowing researchers to study how it interacts with brain signals that control appetite. Researchers investigate Eloralintide for its ability to signal to the brain that the body is satisfied, helping to manage hunger and energy levels without causing unwanted side effects on other systems.

Findings from early-stage clinical trials have reported:

• Improved adaptation to satiety signaling and steady reductions in daily calorie intake observed across multiple study cohorts
• Reductions in overall body fat and total body weight measurements reported in experimental models
• Improvements in overall metabolic health, including healthier blood sugar and cholesterol levels, noted in long-term investigations
• Favorable comfort levels with a much lower rate of stomach upset and nausea compared to older, non-selective alternatives

Researchers study Eloralintide to explore its utility in understanding how the brain and digestive system communicate to manage hunger and weight. By focusing on how the peptide targets specific hunger centers in the brain, it serves as a valuable tool for investigating new ways to treat obesity and metabolic issues without relying on traditional diabetes-style pathways. Its long-lasting formula makes it a primary focus for modern research into sustainable, long-term weight management.

This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use